高级检索

类Gitelman综合征发病机制的研究进展

Research progress of the pathogenesis of Gitelman-like syndrome

  • 摘要: Gitelman综合征(Gitelman syndrome,GS)又称家族性低钾低镁血症,是编码肾远曲小管(distal convoluted tubule,DCT)的噻嗪类利尿剂敏感的钠-氯共转运体(sodium-chloride cotransporter,NCC)基因突变导致的低钾失盐性肾小管疾病,以低钾性碱中毒和低镁血症为特征。GS目前主要的致病基因有SLC12A3基因、KCNJ10基因、HNF1B基因等。类Gitelman综合征是指与GS的临床表现相同,但未检测出经典基因突变的一类综合征,存在与GS不完全相同的致病机制。本文从遗传因素(线粒体基因变异、SLC26A4基因突变、BSND基因突变等)和非遗传因素(利尿剂滥用、氨基糖胺类抗生素、顺铂等)总结类Gitelman综合征的发病机制,为进一步认识和诊治该疾病提供理论依据。

     

    Abstract: Gitelman syndrome (GS), also known as familial hypokalemia and hypomagnesemia, is a hypokalemic renal tubular disease caused by mutation in gene encoding the renal thiazide-sensitive sodium-chloride cotransporter (NCC), which is expressed in the distal convoluted tubule (DCT). GS is characterized by hypokalemic alkalosis and hypomagnesemia. At present, the main pathogenic genes of GS are SLC12A3 gene, KCNJ10 gene, HNF1B gene and so on. Gitelman-like syndrome has the same clinical manifestation as GS, but no classic gene mutation. It has not exactly the same pathogenic mechanism as GS. This paper summarizes the pathogenesis of Gitelman-like syndrome from genetic factors (mitochondrial gene variation, SLC26A4 gene mutation, BSND gene mutation, etc.) and non-genetic factors (diuretic abuse, aminoglycosamine antibiotics, cisplatin, etc.), in order to provide theoretical basis for further understanding, diagnosis and treatment of the disease.

     

/

返回文章
返回